AHB(SH:688639) Xin Lang Cai Jing·2026-01-15 05:32Group 1 - The core point of the news is that Huaheng Biological experienced a decline of 5.22% in its stock price, reaching 37.80 CNY per share, with a trading volume of 464 million CNY and a turnover rate of 4.77%, resulting in a total market capitalization of 9.454 billion CNY [1] - Huaheng Biological, established on April 13, 2005, and listed on April 22, 2021, is primarily engaged in the research, production, and sales of amino acids and their derivatives, with the main revenue composition being 70.96% from amino acid series, 20.96% from other supplements, 5.34% from vitamins, and 2.74% from other products [1] Group 2 - From the perspective of major circulating shareholders, the fund under Jiao Yin Schroder has reduced its holdings in Huaheng Biological by 3.8368 million shares, now holding 4.3135 million shares, which accounts for 1.72% of the circulating shares, resulting in an estimated floating loss of approximately 8.9721 million CNY [2] - The Jiao Yin Advanced Manufacturing Mixed A fund, managed by Guo Ruo, has a total asset scale of 4.497 billion CNY, with a year-to-date return of 3.32% and a one-year return of 55.55% [2][3] Group 3 - The Jiao Yin Advanced Manufacturing Mixed A fund has Huaheng Biological as its seventh-largest heavy stock, with the reduced holdings accounting for 3.05% of the fund's net value, leading to an estimated floating loss of about 8.9721 million CNY [4]